| Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect Adrenergic Receptor Agonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect Adrenergic Receptor Agonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect Adrenergic Receptor Agonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect Adrenergic Receptor Agonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect Adrenergic Receptor Agonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect Adrenergic Receptor Agonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect Adrenergic Receptor Agonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect Adrenergic Receptor Agonist: NET inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect Adrenergic Receptor Agonist: NET and DA inhibitor |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect Adrenergic Receptor Antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect Adrenergic Receptor Antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect Adrenergic Receptor Antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nonselective alpha Receptor Antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nonselective alpha Receptor Antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha 1 Receptor Antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha 1 Receptor Antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha 1 Receptor Antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha 1 Receptor Antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha 2 Receptor Antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mixed Adrenergic Receptor Antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mixed Adrenergic Receptor Antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nonselective Beta Antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nonselective Beta Antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nonselective Beta Antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nonselective Beta Antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alkaloid Direct Acting Muscarinic Agonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alkaloid Direct Acting Muscarinic Agonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Choline Ester Direct Acting Muscarinic Agonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Choline Ester Direct Acting Muscarinic Agonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Choline Ester Direct Acting Muscarinic Agonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Choline Ester Direct Acting Muscarinic Agonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Direct Acting Nicotinic Agonist/Antagonist (NN and NM) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Direct Acting Nicotinic Partial Agonist (NN) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Direct Acting Nicotinic Agonist/Antagonist (NM) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Direct Acting Nicotinic Agonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Direct Acting Nicotinic Agonist |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect Acting Cholinomimetics: Reversible |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect Acting Cholinomimetics: Reversible |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect Acting Cholinomimetics (Tertiary): Reversible |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect Acting Cholinomimetics: Reversible |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect Acting Cholinomimetics: Reversible |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect Acting Cholinomimetics: Reversible |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect Acting Cholinomimetics: Irreversible |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect Acting Cholinomimetics: Irreversible |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect Acting Cholinomimetics: Irreversible |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indirect Acting Cholinomimetics: Irreversible |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Muscarinic (Respiratory, Quat) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Muscarinic (Respiratory) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Muscarinic (Urge Incontinence) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Muscarinic (Urge Incontinence) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Muscarinic (Urge Incontinence) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Muscarinic (Urge Incontinence, Quat) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Muscarinic (Urge Incontinence) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Muscarinic (Urge Incontinence) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Muscarinic (anti-Parkinson) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Muscarinic (anti-Parkinson) |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Ganglionic Blocker (Cholinolytic) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Ganglionic Blocker (Cholinolytic) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Ganglionic Blocker (Cholinolytic) |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Parkinsons. D4. Severe Nausea |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Parkinson. D3. Hallucinations/Sleep attacks. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Parkinson. D3. Hallucination/Sleep attacks. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-Parkinson. Entacapone + Levadopa/Carbedopa |  | 
        |  |